metricas
covid
Buscar en
Cirugía Española
Toda la web
Inicio Cirugía Española Biopsia de mama guiada por arpón para lesiones mamográficas: experiencia en nu...
Información de la revista
Vol. 71. Núm. 1.
Páginas 9-13 (enero 2002)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 71. Núm. 1.
Páginas 9-13 (enero 2002)
Acceso a texto completo
Biopsia de mama guiada por arpón para lesiones mamográficas: experiencia en nuestro hospital
Needle-guided breast biopsy in mammographic lesions: Experience in our hospital
Visitas
13811
L.A. Magrach1
Autor para correspondencia
lmb0003@wanadoo.es

Correspondencia: L.A. Magrach Barcenilla. P.º de Pastrana, 39, 2.º D. 28803 Alcalá de Henares. Madrid.
Servicio de Cirugía General y Aparato Digestivo. Hospital Clínica Puerta de Hierro. Madrid
Este artículo ha recibido
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
Resumen
Introducción

La detección temprana del cáncer de mama se ha beneficiado del creciente uso de la mamografía de cribado y de las biopsias de mama para las lesiones no palpables

Pacientes y método

Hemos revisado la efectividad de la biopsia guiada por arpón para lesiones mamográficas de 84 pacientes que acudieron o fueron remitidas a nuestro hospital durante un período de 4 años

Resultados

Se detectó malignidad en 24 de las 84 biopsias (28%). La rentabilidad de la biopsia fue mayor para los hallazgos mamográficos de masas espiculadas o estrelladas (50%; p < 0,01). La mayoría de las biopsias (77%) fueron llevadas a cabo debido al hallazgo de microcalcificaciones, masas circunscritas aumentadas de tamaño o nódulos bien definidos con una tasa de biopsias positivas del 23%. Las tasas fueron mayores en pacientes con antecedentes personales (29%) o familiares (55%) de cáncer de mama y en pacientes posmenopáusicas (25%)

Conclusiones

Estos resultados demuestran que factores como la edad, la historia personal o familiar de cáncer de mama y ciertas características mamográficas de lesiones mamarias están asociados con altas tasas de positividad de las biopsias, siendo la tasa de rentabilidad de la biopsia comparable a la de otros hospitales

Palabras clave:
Lesiones de mama no palpables
Diagnóstico temprano del cáncer de mama
Biopsia guiada con arpón
Tratamiento conservador
Introduction

The growing use of mammographic screening and breast biopsies has improved the early detection of nonpalpable breast lesions

Patients and methods

We assessed the effectiveness of needle-guided biopsy in nonpalpable radiographic abnormalities in 84 patients who attended or were referred to our hospital over a 4-year period

Results

Malignancy was detected in 24 of 84 biopsies (28%). Biopsy yield was highest for mammographic findings of spiculated or stellate masses (50%, p < 0.01). Most biopsies (77%) were performed because of mammographic findings of microcalcifications, enlargement circumscribed masses, or well-defined nodular densities with a positive biopsy rate of 23%. Rates were higher in patients with a personal (29%) or family history (55%) of breast cancer and in postmenopausal women (25%)

Conclusions

These results demonstrate that factors such as age, a personal or family history of breast cancer, and certain mammographic features of breast lesions are associated with positive biopsy rates. The biopsy yield in this study was similar to that of other hospitals

Key words:
Nonpalpable breast lesions
Early diagnosis of breast cancer
Needle-guided biopsy
Conservative treatment
El Texto completo está disponible en PDF
Bibliografía
[1.]
J. Subh Subh, F. Delgado Gomis, I. Vizcaíno Esteve, J.L. Ponce Marco, V. Torres Gil, J. Martin Delgado.
Aspectos diagnósticos y terapéuticos de las lesiones de mama no palpables. Estudio en 160 biopsias.
Cir Esp, 67 (2000), pp. 38-44
[2.]
B. Cady, M.D. Stone, J.G. Schuler.
The new era in breast cancer: invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening.
Arch Surg, 131 (1996), pp. 301-308
[3.]
P. Strax.
Detection of breast cancer.
Cancer, 66 (1990), pp. 1336-1340
[4.]
E.E. Sterns.
The abnormal mammogram in women with clinically normal breast.
Can J Surg, 38 (1995), pp. 168-172
[5.]
G.F. Schwartz, D.L. Carter, E.F. Conat.
Mammographically detected breast cancer: Nonpalpable is not a synonym for inconsequential.
Cancer, 73 (1994), pp. 1660-1665
[6.]
H. Opie, N.C. Estes, W.R. Jewell.
Breast biopsy for non palpable lesions. A worthwhile endeavor?.
Am Surg, 59 (1993), pp. 490-494
[7.]
P.O. Hasselgreen, R.P. Hummel, M.A. Fieler.
Breast biopsy with needle localization: influence of age and mammographic feature on the rate of malignancy in 350 nonpalpable lesions.
Surgery, 110 (1991), pp. 623-628
[8.]
J.E. Meyer, T.J. Eberlein, P.C. Stomper, M.R. Sonnenfeld.
Biopsy of occult breast lesions: analysis of 1261 abnormalities.
JAMA, 263 (1990), pp. 2341-2343
[9.]
American College of Radiology, (1995),
[10.]
E.S. De Paredes, T.G. Langer, J. Cousins.
Interventional breast procedures.
Curr Probl Diagn Radiol, 27 (1998), pp. 133-184
[11.]
M.C. Wilhelm, S.B. Edge, D.D. Cole.
Nonpalpable invasive breast cancer.
Ann Surg, 213 (1991), pp. 600-605
[12.]
D. Franceschi, J.P. Crowe, S. Lie.
Not all nonpalpable breast cancer are alike.
Arch Surg, 126 (1991), pp. 967-971
[13.]
M.J. Silverstein, P. Gamagami, W.J. Colburn.
Nonpalpable breast lesions: diagnosis with slightly overpenetrated film-screen mammography and hook wire directed biopsy in 1,014 cases.
Radiology, 171 (1989), pp. 633-638
[14.]
W.R. Thompson, J.R. Bowen, B.A. Dorman.
Mammographic localization and biopsy of nonpalpable breast lesions: a 5-year study.
Arch Surg, 126 (1991), pp. 730-734
[15.]
A.E. Papatestas, D. Hermann, G. Hermann.
Surgery for nonpalpable lesions.
Arch Surg, 125 (1990), pp. 399-402
[16.]
E. Frykberg, K.I. Bland.
Overview of the biology and management of ductal carcinoma in situ.
Cancer, 74 (1994), pp. 350-362
[17.]
M.J. Silverstein, J.R. Waisman, P. Gamagami, E.D. Gierson, W.J. Colburn, R.J. Rosse, et al.
Intraductal carcinoma of the breast (208 cases): clinical factors influencing treatment choice.
Cancer, 66 (1990), pp. 102-108
[18.]
A. Sierra, F. Fernández, J. González, E. Lanzós, C. Fernández, A.A. Carrillo, et al.
Resultados del tratamiento conservador del cáncer de mama. A propósito de 218 casos estudiados.
Cir Esp, 57 (1995), pp. 421-426
[19.]
M.J. Silverstein, D. Poller, J. Waisman, W. Colburn, A. Barth, E. Gierson, et al.
Prognostic clasification of breast ductal carcinoma in situ.
Lancet, 345 (1995), pp. 1154-1157
[20.]
M.D. Lagios.
Ductal carcinoma in situ. Pathology and treatment.
Surg Clin North Am, 70 (1990), pp. 853-871
[21.]
M.J. Silverstein, E.D. Gierson, W.J. Colburn, L.M. Cope, M. Furmanski, G.M. Senofsky, et al.
Can intraductal breast carcinoma be excised completely by local excision?.
Cancer, 73 (1994), pp. 2985-2989
[22.]
M.D. Lagios, P.R. Westdahl, F.R. Margolin, M.R. Rose.
Duct carcinoma in situ: relationship of extent of noninvasive disease to the frecuency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures.
Cancer, 50 (1982), pp. 1309-1314
[23.]
A.C. Voogd, F. Van Der Horst, M.A. Crommelin, J.L. Peterse, M.W. Van Beek, O.J. Repelaer Van Driel.
The relationship between findings on pre-treatment mamograms and local recurrence after breast-conserving therapy for invasive breast cancer.
Eur J Surg Oncol, 25 (1999), pp. 273-279
[24.]
J. White, A. Levine, G. Gustafson, K. Wimbish, J. Ingold, J. Pettinga, et al.
Outcome and prognostic factors for local recurrence in mamographically detected DCIS of the breast treated by surgery and radiation therapy.
Int J Radiat Oncol Biol Phys, 31 (1995), pp. 791-797
[25.]
D.E. Fisher, S.J. Schnitt, R. Christian, J.R. Harris, I.C. Henderson.
Chest wall recurrence of ductal carcinoma in situ of the breast after mastectomy.
Cancer, 71 (1993), pp. 3025-3028
[26.]
L.J. Solin, I.T. Yeh, J. Kurtz, A. Fourquet, A. Recht, R. Kuske, et al.
Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast conserving surgery and definitive irradiation: correlation of pathologic parameters with outcome of treatment.
Cancer, 71 (1993), pp. 2532-2542
[27.]
B. Zafrani, A. Fourquet, J.R. Vilcoq, M. Legal, R. Calle.
Conservative management of intraductal breast carcinoma with tumorectomy and radiation therapy.
Cancer, 57 (1986), pp. 1299-1301
[28.]
J.M. Metz, L.J. Solin.
Long term outcome after postmastectomy radiation therapy for the treatment of ductal carcinoma in situ of the breast.
Am J Clin Oncol, 22 (1999), pp. 215-217
[29.]
L.J. Solin, J. Kurtz, A. Fourquet, R. Amalric, A. Recht, B.A. Barnstein, et al.
Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast.
J Clin Oncol, 14 (1996), pp. 754-763
[30.]
M.J. Silverstein, E.D. Gierson, W.J. Colburn, R.J. Rosser, J.R. Waisman, P. Gamagami.
Axilary lymphadenectomy for intraductal carcinoma of the breast.
Surg Gynecol Obstet, 172 (1991), pp. 211-214
[31.]
K.B. Clough, C. Nos, D. Bourgeois.
Indication des prelevements des lesions mammaires non palpables.
Arch Anat Cytol Pathol, 46 (1998), pp. 223-225
[32.]
P.T. Huynh, A.M. Jarolimek, S. Daye.
The false-negative mamogram.
Radiographics, 18 (1998), pp. 1137-1154
[33.]
P. Skaane.
The additional value of US to mammography in the diagnosis of breast cancer. A prospective study.
Acta Radiol, 40 (1999), pp. 486-490
[34.]
C.S. Huang, C.Y. Wu, J.S. Chu, J.H. Lin, S.M. Hsu, K.J. Chang.
Microcalcifications of non palpable breast lesions detected by ultrasonography: correlation with mammography and histopathology.
Ultrasound Obstet Gynecol, 13 (1999), pp. 431-436
[35.]
B.C. Lein, W.R. Alex, M. Zebley, C.M. Pezzi.
Results of needle localized breast biopsy in women under age 50.
Am J Surg, 171 (1996), pp. 356-359
[36.]
G. Manzanet, E. Marcote, M. Romero, M. Canales, M.A. Lázaro, M.D. Yago, et al.
Modificación técnica de la biopsia mamaria guiada con arpón en las lesiones no palpables.
Cir Esp, 61 (1997), pp. 233-239
[37.]
R.E. Symmonds, J.W. Roberts.
Management of nonpalpable breast abnormalities.
Ann Surg, 205 (1987), pp. 520-528
[38.]
G. Pastore, P. Marano, M. Romani, M. Constantini, P. Belli.
Critical review of 215 cases of non palpable mammary lesions.
Radiol Med Torino, 97 (1999), pp. 344-348
[39.]
B.D. Matthews, G.B. Williams.
Initial experience with the advanced breast biopsy instrumentation system.
Am J Surg, 177 (1999), pp. 97-101
[40.]
D. Sheth, C.A. Wesen, D. Schroder, J.E. Boccaccio, L.R. Lloyd.
The advanced breast biopsy instrumentation (ABBI) experience at a community hospital.
Am Surg, 65 (1999), pp. 726-730
Copyright © 2002. Asociación Española de Cirujanos
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos